"La Maddalena spa ha la sua sede sanitaria e amministrativa nel comune di Palermo. La Maddalena Spa è una delle realtà sanitarie private più conosciute e apprezzate sull’isola siciliana per la completezza dei suoi servizi e per le ottime prestazioni medico-sanitarie. La Maddalena Spa è una Casa di Cura di “alta specialità”, dispone di un dipartimento Oncologico di III Livello Medico Chirurgico, di un dipartimento Antalgico Ematoncologico con unità specializzate nel trapianto di midollo osseo e un dipartimento di Radioterapia Oncologica e di Microchirurgia Oculare. La Maddalena Spa offre una solida e attrezzata struttura diagnostica con TAC, PET e tomografia a emissioni di positroni e un qualificato laboratorio analisi e anatomia patologica."

During the past decade, Casa di Cura La Maddalena conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 9 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Casa di Cura La Maddalena" #1 sponsor was "National Cancer Institute, Naples" with 11 trials, followed by "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 10 trials sponsored, "Fondazione Ricerca Traslazionale" with 5 trials sponsored, "Celgene" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Casa di Cura La Maddalena" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 2 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 2 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 2 trials as a collaborator and "Gruppo Oncologico Italiano di Ricerca Clinica" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Casa di Cura La Maddalena" are "Breast Cancer" (4 trials), "Leukemia" (4 trials), "Advanced Breast Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials) and "Chronic Myeloid Leukemia" (3 trials). Many other conditions were trialed in "Casa di Cura La Maddalena" in a lesser frequency.

Most popular intervention types in "Casa di Cura La Maddalena" are "Drug" (48 trials), "Procedure" (4 trials), "Other" (3 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (6 trials), "gemcitabine" (4 trials), "Carboplatin" (3 trials), "Cisplatin" (3 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Casa di Cura La Maddalena" are 52 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Casa di Cura La Maddalena". undefined are not yet recruiting, 5 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Casa di Cura La Maddalena, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Casa di Cura La Maddalena, 0 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Casa di Cura La Maddalena has several departments that took part in Clinical trials: "Casa di Cura La Maddalena, Divisione di Ematologia" - 8 trials, "Dipartimento Oncologico La Maddalena" - 5 trials, "Oncoematologia e TMO Dipartimento Oncologico" - 2 trials